| 198 | 0 | 41 |
| 下载次数 | 被引频次 | 阅读次数 |
临床药师参与1例妊娠合并干燥综合征伴免疫性血小板减少症患者的药物治疗过程,从药物选择时机、药物安全性及有效性等方面提供全程药学监护。根据患者血小板水平,先后使用不同药物升血小板治疗;病情缓解后行剖宫产术终止妊娠,过程顺利,未发生药物相关的不良反应。妊娠期患者用药应充分考虑母儿的用药安全,临床药师通过提供个体化用药服务,促进临床合理用药,提高治疗药物的有效性、安全性以及患者的依从性。
Abstract:[1]邵美琳,马艳,厉小梅.干燥综合征合并妊娠的管理[J].中华风湿病学杂志,2021,25(7):485.
[2]易国祥,吴斌.干燥综合征影响妊娠及其结局的研究进展[J].现代妇产科进展,2020,29(11):872.
[3]张文,厉小梅,徐东,等.原发性干燥综合征诊疗规范[J].中华内科杂志,2020,59(4):269.
[4]中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J],中华血液学杂志,2020,41(8):617.
[5]NEUNERT C,TERRELL D R,ARNOLD D M,et al.American Society of Hematology 2019 guidelines for immune thrombocytopenia[J].Blood Adv,2019,3(23):3829.
[6]ANDREOLI L,BERTSIAS G K,AGMON-LEVIN N,et al.EULAR recommendations for women's health and the management of family planning,assisted reproduction,pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome[J].Ann Rheum Dis,2017,76(3):476.
[7]NIRK E L,REGGIORI F,MAUTHE M.Hydroxychloroquine in rheumatic autoimmune disorders and beyond[J].EMBO Mol Med,2020,12(8):e12476.
[8]SEO M R,CHAE J,KIM Y M,et al.Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia[J].Lupus,2019,28(6):722.
[9]CHI C C,KIRTSCHIG G,ABERER W,et al.Updated evidencebased(S2e)European Dermatology Forum guideline on topical corticosteroids in pregnancy[J].J Eur Acad Dermatol Venereol,2017,31(5):761.
[10]ANDERSON G G,ROTCHELL Y,KAISER D G.Placental transfer of methylprednisolone following maternal intravenous administration[J].Am J Obstet Gynecol,1981,140(6):699.
[11]侯明,刘新光.立足中国实际的原发免疫性血小板减少症诊治:2020版成人原发免疫性血小板减少症诊断与治疗中国指南解读[J].临床血液学杂志,2021,34(1):1.
[12]SIRAGAM V,CROW A R,BRINC D,et al.Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells[J].Nat Med,2006,12(6):688.
[13]PROVAN D,ARNOLD D M,BUSSEL J B,et al.Updated internatio nal consensus repo rt on the investigation and management of primary immune thrombocytopenia[J].Blood Adv,2019,3(22):3780.
[14]王先利,曾涛,杨振宇.环孢霉素A对妊娠的调节作用[J].中国现代应用药学,2015,32(5):629.
[15]张文,李懿莎,刘冬舟,等.风湿性疾病患者围妊娠期药物使用规范[J].中华内科杂志,2021,60(11):946.
[16]DAWES M, CHOWIENCZYK P J.Drugs in pregnancy.pharmacokinetics in pregnancy[J].Best Pract Res Clin Obstet Gynaecol,2001,15(6):819.
[17]ERICKSON-MILLER C L,DELORME E,TIAN S S,et al.Preclinical activity of eltrombopag(SB-497 115),an oral,nonpeptide thrombopoietin receptor agonist[J].Stem Cells,2009,27(2):424.
[18]MICHEL M,RUGGERI M,GONZALEZ-LOPEZ T J,et al.Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy:results from a multicenter study[J].Blood,2020,136(26):3056.
[19]AGARWAL N,MANGLA A.Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy:a narrative review[J].Ther Adv Hematol,2021,12:20406207211001139.
[20]专家组.糖皮质激素类药物临床应用指导原则[J].中华内分泌代谢杂志,2012,28(2):171.
[21]PALMSTEN K,ROLLAND M,HEBERT M F,et al.Patterns of prednisone use during pregnancy in women with rheumatoid arthritis:daily and cumulative dose[J].Pharmacoepidemiol Drug Saf,2018,27(4):430.
[22]中国医师协会风湿免疫科医师分会,中华医学会风湿病学分会,中华医学会骨质疏松和骨矿盐疾病分会,等.2020版中国糖皮质激素性骨质疏松症防治专家共识[J].中华内科杂志,2021,60(1):13.
[23]SHOENFELD Y,GUREWICH Y,GALLANT L A,et al.Prednisone-induced leukocytosis.Influence of dosage,method and duration of administration on the degree of leukocytosis[J].Am J Med,1981,71(5):773.
[24]中华医学会围产医学分会.妊娠期铁缺乏和缺铁性贫血诊治指南[J].中华围产医学杂志,2014(7):451.
[25]黄晓娜,庞艳玉.妊娠合并抗磷脂综合征并发血小板减少患者的药学监护[J].中国临床药学杂志,2021,30(2):133.
[26]GOTESTAM SKORPEN C,HOELTZENBEIN M,TINCANI A,et al.The EULAR points to consider for use of antirheumatic drugs before pregnancy,and during pregnancy and lactation[J].Ann Rheum Dis,2016,75(5):795.
[27]BRAMHAM K,CHUSNEY G,LEE J,et al.Breastfeeding and tacrolimus:serial monitoring in breast-fed and bottle-fed infants[J].Clin J Am Soc Nephrol,2013,8(4):563.
基本信息:
DOI:10.19577/j.1007-4406.2023.01.014
中图分类号:R969.3
引用信息:
[1]何冠兰,凌春燕.临床药师参与1例妊娠合并干燥综合征伴免疫性血小板减少症患者的药学实践[J].中国临床药学杂志,2023,32(01):66-70.DOI:10.19577/j.1007-4406.2023.01.014.
基金信息:
广西壮族自治区卫生健康委员会课题(编号Z20210341)
2023-01-25
2023-01-25